One of the most common inflammatory markers examined in depression is C-reactive protein (CRP). However, the magnitude of the association between CRP and depression when controlling for potentially confounding factors such as age, sex, socio-economic status, body mass index, medication and other substance use, and medical illness, is unclear. Inconsistencies in other methodological practices, such as sample collection, assaying, and data cleaning and transformation, may contribute to variations in results. We aggregate studies that examined the association between CRP and depression in two ways. First, a systematic review summarizes how studies of CRP and depression have reported on methodological issues. Second, a tiered meta-analysis aggregates studies that have adhered to various levels of methodological rigor. Findings from the systematic review indicate a lack of protocol detail provided. The effect between depression and CRP was small, but highly significant across all stages of the meta-analysis (p < 0.01). The effect size in the most methodologically rigorous stage of the meta-analysis, which included studies controlling for age, sex, obesity, medical conditions and substance, medication, or psychosocial factors, was small (r = 0.05). There were also only 26 articles in this stage (13% of studies from the systematic review), suggesting that more studies that consistently account for these confounding factors are needed. Additionally, an a priori quality score of methodological rigor was a significant moderator in this stage of the meta-analysis. The effect size was strikingly attenuated (r = 0.005) and non-significant in studies with higher quality scores. We describe a set of recommended guidelines for future research to consider, including sample collection and assaying procedures, data cleaning and statistical methods, and control variables to assess.
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Major Depressive Disorder (MDD) is a disabling and prevalent mental health condition associated with significant mental and physical health comorbidity (Ferrari et al., 2013; Kessler et al., 2003; Vancampfort et al., 2014) . Although several pathways have been implicated in the relationship between depression and physical health, inflammatory processes have garnered considerable attention in psychological research as potential biological mechanisms (Kiecolt-Glaser and Glaser, 2002; Miller, 1998; Miller et al., 2009; Raison et al., 2006) . The macrophage theory of depression postulates that pro-inflammatory cytokines are secreted by activated macrophages, contributing to the onset or exacerbation of depression (Smith, 1991) . Further, depressive symptoms (e.g., depressed mood, anhedonia, loss of appetite) are associated with acute infections and elevated cytokine levels (Dantzer and Kelley, 2007; Maier and Watkins, 1998) . Notably, common physical health comorbidities observed in patients with depression, such as cardiovascular disease (CVD) (Elderon and Whooley, 2013) , diabetes mellitus (DM) (Anderson et al., 2001) , and autoimmune disorders (e.g., rheumatoid arthritis and lupus; (Benros et al., 2013) are characterized by robust disruptions in immunological functioning.
One of the most frequently studied inflammatory biomarkers is Creactive protein (CRP), a pentameric protein that increases in level during the acute phase of inflammation (Du Clos, 2000) . In 2009, Howren and colleagues published the first meta-analysis on depression and CRP, demonstrating that depression and CRP were positively associated in clinical and community samples (Howren et al., 2009 ). These results were substantiated with further meta-analytic studies (Haapakoski et al., 2015; Valkanova et al., 2013) . Despite the preliminary evidence for the role of CRP in depression, effect sizes in these meta-analyses were attenuated after controlling for body mass index (BMI) or medication use (Haapakoski et al., 2015; Howren et al., 2009) . Furthermore, some large-scale studies have failed to establish an association between CRP and depression (de Menezes et al., 2017; Steptoe 
